As of October 2022, one new biosimilar drug became available in the United States in that year, compared to seven biosimilars that became available during 2019. This statistic illustrates the number of biosimilar drugs becoming available in the United States from 2015 to 2022.
Number of biosimilars becoming available in the United States from 2015 to 2022
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Amgen. (October 31, 2022). Number of biosimilars becoming available in the United States from 2015 to 2022 [Graph]. In Statista. Retrieved January 08, 2025, from https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/
Amgen. "Number of biosimilars becoming available in the United States from 2015 to 2022." Chart. October 31, 2022. Statista. Accessed January 08, 2025. https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/
Amgen. (2022). Number of biosimilars becoming available in the United States from 2015 to 2022. Statista. Statista Inc.. Accessed: January 08, 2025. https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/
Amgen. "Number of Biosimilars Becoming Available in The United States from 2015 to 2022." Statista, Statista Inc., 31 Oct 2022, https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/
Amgen, Number of biosimilars becoming available in the United States from 2015 to 2022 Statista, https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/ (last visited January 08, 2025)
Number of biosimilars becoming available in the United States from 2015 to 2022 [Graph], Amgen, October 31, 2022. [Online]. Available: https://www.statista.com/statistics/1186603/number-biosimilar-drugs-becoming-available-us/